A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases

Mutsumi Omori, Satoshi Takeuchi, Akari Tashiro, Takeshi Nakahara, Chikage Mitoma, Hiroshi Terao, Yasushi Urata, Eri Yoshimura, Kyoko Kudo, Shinsuke Yasukawa, Jun Tsujita, Hisashi Kokuba, Kana Masunaga, Kentaro Kuwahara, Ryutaro Ichikawa, Eriko Ito, Hiromichi Takeshita, Fumiko Yasukawa, Atsuko Nishie, Yoichi MoroiMasutaka Furue

Research output: Contribution to journalArticle

Abstract

A total of 107 patients with pruritic skin diseases (mean age 52.1±19.0 years, male : female = 45: 62) who visited Kyushu University Hospital and other related institutions from May to December 2008 were enrolled and treated with bepotastine besilate twice daily for at least a week. A questionnaire survey was then conducted and analyzed for the clinical efficacy of the antihistamine in improving pruritus, daytime sleepiness, nocturnal sleeping time, and time to sleep onset. Improvement of daytime and nocturnal pruritus were 88.6% and 89.5% overall, respectively. The urticaria group showed significantly more improvement in daytime and nocturnal pruritus (94.3% and 97.1%, respectively), compared with the eczema/dermatitis group (87.2% and 89.4%, respectively; p<0.05). Some patients (13.2%) complained of intolerable daytime sleepiness, but 64.3% of such "sleepy" patients wished to continue the use of the antihistamine, perhaps because of the high anti-pruritic efficacy in these patients (92.9%). Time to sleep onset was shortened in 27.2% of all subjects, but nocturnal sleeping time didn't change in 81.8% of patients. The antihistamine was effective for the control of pruritus in patients who had been treated with other antihistamines before examination as well as those who had not. High utility and patient satisfaction was demonstrated, as 79.4 % of all subjects wished to continue use of this second generation, non-sedative antihistamine.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalNishinihon Journal of Dermatology
Volume72
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Skin Diseases
Histamine Antagonists
Pruritus
Sleep
Therapeutics
Eczema
Urticaria
Dermatitis
Patient Satisfaction
bepotastine besilate
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases. / Omori, Mutsumi; Takeuchi, Satoshi; Tashiro, Akari; Nakahara, Takeshi; Mitoma, Chikage; Terao, Hiroshi; Urata, Yasushi; Yoshimura, Eri; Kudo, Kyoko; Yasukawa, Shinsuke; Tsujita, Jun; Kokuba, Hisashi; Masunaga, Kana; Kuwahara, Kentaro; Ichikawa, Ryutaro; Ito, Eriko; Takeshita, Hiromichi; Yasukawa, Fumiko; Nishie, Atsuko; Moroi, Yoichi; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 72, No. 3, 2010, p. 240-245.

Research output: Contribution to journalArticle

Omori, M, Takeuchi, S, Tashiro, A, Nakahara, T, Mitoma, C, Terao, H, Urata, Y, Yoshimura, E, Kudo, K, Yasukawa, S, Tsujita, J, Kokuba, H, Masunaga, K, Kuwahara, K, Ichikawa, R, Ito, E, Takeshita, H, Yasukawa, F, Nishie, A, Moroi, Y & Furue, M 2010, 'A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases', Nishinihon Journal of Dermatology, vol. 72, no. 3, pp. 240-245. https://doi.org/10.2336/nishinihonhifu.72.240
Omori, Mutsumi ; Takeuchi, Satoshi ; Tashiro, Akari ; Nakahara, Takeshi ; Mitoma, Chikage ; Terao, Hiroshi ; Urata, Yasushi ; Yoshimura, Eri ; Kudo, Kyoko ; Yasukawa, Shinsuke ; Tsujita, Jun ; Kokuba, Hisashi ; Masunaga, Kana ; Kuwahara, Kentaro ; Ichikawa, Ryutaro ; Ito, Eriko ; Takeshita, Hiromichi ; Yasukawa, Fumiko ; Nishie, Atsuko ; Moroi, Yoichi ; Furue, Masutaka. / A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases. In: Nishinihon Journal of Dermatology. 2010 ; Vol. 72, No. 3. pp. 240-245.
@article{c97cc545a3214b1a9c11c1d3fbbd67d6,
title = "A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases",
abstract = "A total of 107 patients with pruritic skin diseases (mean age 52.1±19.0 years, male : female = 45: 62) who visited Kyushu University Hospital and other related institutions from May to December 2008 were enrolled and treated with bepotastine besilate twice daily for at least a week. A questionnaire survey was then conducted and analyzed for the clinical efficacy of the antihistamine in improving pruritus, daytime sleepiness, nocturnal sleeping time, and time to sleep onset. Improvement of daytime and nocturnal pruritus were 88.6{\%} and 89.5{\%} overall, respectively. The urticaria group showed significantly more improvement in daytime and nocturnal pruritus (94.3{\%} and 97.1{\%}, respectively), compared with the eczema/dermatitis group (87.2{\%} and 89.4{\%}, respectively; p<0.05). Some patients (13.2{\%}) complained of intolerable daytime sleepiness, but 64.3{\%} of such {"}sleepy{"} patients wished to continue the use of the antihistamine, perhaps because of the high anti-pruritic efficacy in these patients (92.9{\%}). Time to sleep onset was shortened in 27.2{\%} of all subjects, but nocturnal sleeping time didn't change in 81.8{\%} of patients. The antihistamine was effective for the control of pruritus in patients who had been treated with other antihistamines before examination as well as those who had not. High utility and patient satisfaction was demonstrated, as 79.4 {\%} of all subjects wished to continue use of this second generation, non-sedative antihistamine.",
author = "Mutsumi Omori and Satoshi Takeuchi and Akari Tashiro and Takeshi Nakahara and Chikage Mitoma and Hiroshi Terao and Yasushi Urata and Eri Yoshimura and Kyoko Kudo and Shinsuke Yasukawa and Jun Tsujita and Hisashi Kokuba and Kana Masunaga and Kentaro Kuwahara and Ryutaro Ichikawa and Eriko Ito and Hiromichi Takeshita and Fumiko Yasukawa and Atsuko Nishie and Yoichi Moroi and Masutaka Furue",
year = "2010",
doi = "10.2336/nishinihonhifu.72.240",
language = "English",
volume = "72",
pages = "240--245",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "3",

}

TY - JOUR

T1 - A questionnaire-based survey on the clinical efficacy of bepotastine besilate in the treatment of patients with pruritic skin diseases

AU - Omori, Mutsumi

AU - Takeuchi, Satoshi

AU - Tashiro, Akari

AU - Nakahara, Takeshi

AU - Mitoma, Chikage

AU - Terao, Hiroshi

AU - Urata, Yasushi

AU - Yoshimura, Eri

AU - Kudo, Kyoko

AU - Yasukawa, Shinsuke

AU - Tsujita, Jun

AU - Kokuba, Hisashi

AU - Masunaga, Kana

AU - Kuwahara, Kentaro

AU - Ichikawa, Ryutaro

AU - Ito, Eriko

AU - Takeshita, Hiromichi

AU - Yasukawa, Fumiko

AU - Nishie, Atsuko

AU - Moroi, Yoichi

AU - Furue, Masutaka

PY - 2010

Y1 - 2010

N2 - A total of 107 patients with pruritic skin diseases (mean age 52.1±19.0 years, male : female = 45: 62) who visited Kyushu University Hospital and other related institutions from May to December 2008 were enrolled and treated with bepotastine besilate twice daily for at least a week. A questionnaire survey was then conducted and analyzed for the clinical efficacy of the antihistamine in improving pruritus, daytime sleepiness, nocturnal sleeping time, and time to sleep onset. Improvement of daytime and nocturnal pruritus were 88.6% and 89.5% overall, respectively. The urticaria group showed significantly more improvement in daytime and nocturnal pruritus (94.3% and 97.1%, respectively), compared with the eczema/dermatitis group (87.2% and 89.4%, respectively; p<0.05). Some patients (13.2%) complained of intolerable daytime sleepiness, but 64.3% of such "sleepy" patients wished to continue the use of the antihistamine, perhaps because of the high anti-pruritic efficacy in these patients (92.9%). Time to sleep onset was shortened in 27.2% of all subjects, but nocturnal sleeping time didn't change in 81.8% of patients. The antihistamine was effective for the control of pruritus in patients who had been treated with other antihistamines before examination as well as those who had not. High utility and patient satisfaction was demonstrated, as 79.4 % of all subjects wished to continue use of this second generation, non-sedative antihistamine.

AB - A total of 107 patients with pruritic skin diseases (mean age 52.1±19.0 years, male : female = 45: 62) who visited Kyushu University Hospital and other related institutions from May to December 2008 were enrolled and treated with bepotastine besilate twice daily for at least a week. A questionnaire survey was then conducted and analyzed for the clinical efficacy of the antihistamine in improving pruritus, daytime sleepiness, nocturnal sleeping time, and time to sleep onset. Improvement of daytime and nocturnal pruritus were 88.6% and 89.5% overall, respectively. The urticaria group showed significantly more improvement in daytime and nocturnal pruritus (94.3% and 97.1%, respectively), compared with the eczema/dermatitis group (87.2% and 89.4%, respectively; p<0.05). Some patients (13.2%) complained of intolerable daytime sleepiness, but 64.3% of such "sleepy" patients wished to continue the use of the antihistamine, perhaps because of the high anti-pruritic efficacy in these patients (92.9%). Time to sleep onset was shortened in 27.2% of all subjects, but nocturnal sleeping time didn't change in 81.8% of patients. The antihistamine was effective for the control of pruritus in patients who had been treated with other antihistamines before examination as well as those who had not. High utility and patient satisfaction was demonstrated, as 79.4 % of all subjects wished to continue use of this second generation, non-sedative antihistamine.

UR - http://www.scopus.com/inward/record.url?scp=77954520446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954520446&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.72.240

DO - 10.2336/nishinihonhifu.72.240

M3 - Article

AN - SCOPUS:77954520446

VL - 72

SP - 240

EP - 245

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 3

ER -